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ABSTRACT 
A CRITICAL REVIEW OF TELOMERASE BIOLOGY AND MODEL SYSTEMS FOR 
THE STUDY OF TELOMERASE 
By Jeremy Charles Aisenberg 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
Virginia Commonwealth University, 2006 
Director: Shawn E. Holt, Ph.D., Associate Professor, Department of Pathology, 
Department of Human Genetics, Department of Pharmacology and Toxicology 
The study of telomere and telomerase biology holds substantial promise in uncovering 
the molecular process of aging and the treatment of cancers. Studies have shown that 
telomere shortening is directly linked to cellular aging and that telomerase expression is 
found in over 85% of human cancers, including 95% of all advanced malignancies. 
Development of effective model systems to elucidate the molecular mechanisms 
underlying the role of telomeres and telomerase in the processes aging and cancer is of 
particular importance. While inbred strains of mice have provided a wealth of 
information for a variety of pathways and diseases, the mouse model poses a challenge 
for the study of telomere biology due to their extremely large telomere sizes. The 
telomerase knockout mouse suffers no adverse effect for at least 6 generations, making 
studies of telomere shortening-associated pathology in single generations of animal 
very difficult. For this reason, the identification of new vertebrate models for the study of 
telomeres and telomerase biology is critical. The chicken, Gallus gallus, has been an 
important model system for the study of embryology and development for decades. The 
chicken has three classes of telomeres, characterized and differentiated by their size. 
Class I ranging from 0.5 to 10 kb in size, Class II ranging between 10 to 40 kb in size, 
and Class Ill ranging between 40 kb to 2 Mb in size. The class I and II chicken 
telomeres are close enough in size to those of humans, which range between 4 and 15 
kb, to allow for chicken studies to elucidate information valuable to the understanding of 
the molecular process in humans. The chicken telomerase genes have been cloned 
and characterized, providing a foundation for unlimited study of telomere biology in the ! I
chicken. Additional models, including many different fish species, will also hold promise I I 
as telomere models for aging and cancer. The development of an additional model of 
telomere biogenesis and telomerase regulation should provide important insights into 
the molecular processes surrounding both the development of cancer and organismal 
aging. 
Chapter 1 
The Telomere and Cellular Aging 
Telomeres are defined as the repetitive DNA sequences at the ends of chromosomes 
and therefore do not contain protein-coding genes. Instead, telomeres have been 
shown to protect the ends of chromosomes from damage and end-to-end fusions 
(Sandell and Zakian, 1993). In vertebrates, the telomere is composed of tandem 
repeats of the sequence TTAGGG (Blackburn, 1999). The telomeres play a critical role 
in the localization of chromosomes within the nucleus as well as proper pairing and 
alignment during meiosis. Most notably, telomeres appear to play a central role in 
cellular aging, senescence, and cell cycle control. 
The cell cycle has been the focus of intense research for more than 50 years. The 
control of timing of cellular events including signaling, development, division and other 
crucial pathways are directly influenced by the cell cycle. The eukaryotic cell cycle 
(Figure 1) includes an M phase, G I  phase, S phase, and G2 phase. lnterphase 
includes GI,  S and G2 phases, while M phase represents Mitosis, during which time the 
cell evenly distributes chromosomes into daughter cells. The S phase is the 
synthesizing phase during which the DNA content of the cell is duplicated. The G 
phases represent the gaps between the end of M phase and S phase (GI) and the end 
of S phase and the beginning of M phase (G2). In addition, many cell types enter the 
GO phase, or resting phase, also known as quiescence, following mitosis. Cells can 
survive in quiescence for a significant amount of time, from days to weeks to months. 
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Figure 1. The Cell Cycle. The cell cycle, including G I ,  S, G2, and M phase as well as 
the growth arrest phase, GO, is represented as a clock and thought to be loosely based 
on a 24-hour period for many cell types. The cyclin and cyclin dependent kinase factors 
that drive transitions between these phases are also illustrated. 
Normal eukaryotic cells were shown by Hayflick to have a finite number of population 
doublings before they reach a stage known as replicative senescence (Reviewed by 
Wright and Shay, 1992). Hayflick found that cells in culture will continue to replicate for 
a given number of population doublings before growth slows and eventually reaches the 
"Hayflick Limit" where no further cell division is observed. This cessation of cell growth 
was later termed cellular senescence. This phenomena is not observed in immortal 
cells such as germ cells, embryonic stem cells, and cell lines derived from tumor cells 
as telomere maintenance is achieved through the expression and activity of the 
telomerase protein, described in significant detail hereunder. 
Senescence is marked by growth arrest during the G I  phase of the cell cycle, is 
irreversible, and is associated with an accumulation of cell cycle regulators p53, p21, 
and p16 (Reviewed in Bringold and Serrano, 2000). These cells are in an irreversible 
arrest phase whereby they are unable to undergo further cell divisions. Senescent cells 
can continue metabolic activities and are therefore not considered dead. Senescent 
cells in culture generally have a larger appearance, and populations of senescent cells 
generally have a heterogeneous size distribution. In culture, senescent cells are 
identifiable after staining for P-galactosidase at pH 6, which was a fortuitous observation 
and one of the clearest molecular and/or histochemical markers of cellular senescence 
(Dimri et al., 1995). Telomere length and shortening in successive replications appears 
to play a pivotal role in triggering the onset of cellular senescence. 
Human telomeres range from 4 to 15 kilobases in length. There is generally a 100-1 50 
base 3' overhang of single stranded TTAGGG repeats. The single stranded overhang 
has been shown to establish a tertiary structure known as T-loops, with associated 
proteins, which shall be discussed in further detail later (Griffith et al., 1999). T-loops 
have been identified in numerous organisms other including humans, and these T-loops 
help form protective end structures at the end of chromosomes to prevent chromosome 
ends from being recognized as damaged DNA. One theory for telomere-induced 
senescence is that erosion of telomeres, hence shortening, causes a conformational 
problem with the formation of the T-loops, thereby preventing the loop from forming and 
allowing telomeres to be bound by DNA repair enzymes. 
Telomeres are believed to serve several critical functions. By capping the chromosome 
ends, they protect critical gene coding regions from loss due to the end replication 
problem described below. In addition, the telomeres protect the free ends of the 
chromosomes from being recognized as damaged DNA and the loss of the telomere is 
believed to trigger a DNA damage pathway leading to cell cycle arrest or apoptosis. 
Telomeric structures help cells to identify the chromosome ends. Without these 
complex proteirdDNA structures, cells would not be able to differentiate from interstitial 
double stranded chromosomal breaks. When telomeres shorten or are uncapped, 
chromosome ends can be subject to degradation, recombination, or end-to-end fusions 
through cellular DNA repair systems (Chan and Blackburn, 2003). 
When telomeres fuse, dicentric chromosomes are created. These abnormal structures 
are not correctly sorted during meiosis and lead to a variety of aberrant outcomes 
generally causing genomic rearrangements in the surviving cells (Gisselsson, 2003). 
Dysfunctional chromosome ends and genomic instability, either through DNA loss or 
protein dysfunction, can lead to a premature decrease in telomere length, which in turn 
can lead to early senescence. Conversely, dysfunctional telomeric elongation can lead 
to a delayed senescent response and a variety of aberrant outcomes. The mechanisms 
for such cellular activities are discussed below. The absence of functional telomeres 
clearly leads to genomic changes, which can lead to cancer and aging as discussed 
below (Gray and Collins, 2000). 
Telomeres shorten in human somatic cells due to the end replication problem (Figure 
2). While human telomeres range in size from 4 to 15 kb, gradual loss of anywhere 
from 50-200 base pairs after every cell division, takes place due to this problem. It has 
- been shown that various cell types can lose from 20 bases (fibroblasts) up to 200 bases 
(epithelial cells). The end replication problem arises due to the absence of a primer for 
the lagging strand of DNA. During cell division, DNA dependent DNA polymerase can 
synthesize DNA on the leading strand to the most terminal point of the chromosome on - 
the leading strand in a 5' to 3' direction. Because replication must proceed 5' to 3', the 
lagging strand is discontinuous in that as the replication fork opens, priming takes place 
followed by replication to the next RNA primer. As replication continues and RNA 
primers are replaced with DNA, the lagging strand is made up of Okazaki fragments that 
are eventually ligated together. However, at the very end of the linear chromosome, 
there is either: 1) not enough DNA for RNA priming to take place, which leaves an 
unreplicated end piece, or 2) the priming event does occur at the very end, and when 
the RNA is removed, there is no Okazaki fragment to attach to, leaving an unreplicated 
fragment. It is likely that both mechanisms contribute to this end replication problem and 
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Figure 2. End Replication Problem. The end replication problem arises during cell 
division when the lagging strand, which uses Okazaki fragments as part of the 
replication process, does not have a site available to prime DNA synthesis at the 
terminal end of the lagging strand. Through repeated replication and cell divisions, 
telomeres become progressively shorter, which is a key mechanism in the onset of 
cellular senescence or apoptotic pathways. 
telomere shortening, all of which was first proposed by a Russian scientist, Alexy 
Olovnikov (1 973). Through repeated replication and cell divisions, telomeres become 
progressively shorter. This shortening of telomeres is likely the trigger to cellular 
senescence or apoptotic pathways. 
Some cell types are not affected by the end replication problem. These include germ 
cells, stem cells, and tumor cells. In these cell types, telomerase has been found to be 
expressed and active. In a small proportion of cancers, telomere lengths are maintained 
or even lengthened in the absence of telomerase activation (discussed in more detail in 
Chapter 4). This pathway is referred to as the ALT pathway (alternative lengthening of 
telomeres) and appears to occur by a recombination process similar to processes seen 
in budding yeast lacking telomerase (Lundblad and Blackburn, 1993). This is a relatively 
minor pathway and is not the focus of the current thesis on telomeres and telomerase, 
although will be discussed in some detail below. 
Chapter 2 
Cellular Immortalization 
Regulation of the cell cycle controls cellular proliferation through a variety of complex 
mechanisms, many of which are still not well understood. The control of cellular 
initiation of M phase is well studied. Mitosis Promoting Factor (MPF) is one transacting 
factor that promotes cellular entry into M phase. MPF consists of two subunits, a cyclin 
dependent kinase and a mitotic cyclin protein. 
Cells are continuously exposed to a variety of stresses that affect function and 
proliferation. Changes that cause genetic mutations are deleterious to the cell's fate as 
when these changes are passed to subsequent generations of daughters, a number of 
various mutant phenotypes can occur, including aberrant and uncontrolled cell division 
leading to human cancers. Cells have evolved a series of comp!ex mechanisms to 
monitor, prevent, or eliminate cells that develop such changes. 
The transcription factor and tumor suppressor gene p53, identified initially as being 
essential in identifying DNA damage, has subsequently been found to have a broader 
role after cellular stresses (Reviewed in Yee and Vousden, 2006). The p53 protein 
functions as a tetrameric protein. It is found constitutively active at low levels in normal 
cells. Many different forms of cellular stress causes activation of a variety of pathways, 
which can cause post-translational changes to p53, affecting its function and increasing 
10 
its stability. Increased p53 stability leads to transcriptional activation of cell cycle 
inhibitory genes and genes involved in apoptosis, such as p21 and GADD45. Genes 
activated or repressed by p53 expression lead to outcomes such as stimulation of DNA 
repair, transient or permanent cell cycle arrest, and apoptosis. 
The retinoblastoma protein, pRB, is another critical protein involved in the regulation of 
cell cycle control. Its level of phosphorylation determines whether or not a cell will 
continue normally through the cell cycle or enter into one of several pathways. High 
levels of phosphorylation of pRB allow the cell cycle to proceed, while low 
phosphorylation levels prevent cell cycle progression. Hypophosphorylated, or under 
phosphorylated, pRB is believed to inactivate the E2F transcription factors, while 
hyperphosphorylation of pRB causes release of E2F and promotion of cell growth. The 
E2F family of transcription factors controls a series of genes necessary for transition 
into the S phase of the cell cycle. 
The phosphorylation level of pRB is dependent upon a variety of cyclin dependent 
kinases (CDK's). A family of proteins, known as cyclin dependent kinase inhibitors 
- (CDKl's) has been shown to interrupt the activity of CDK's. Disruption of CDK activity 
during G I  of the cell cycle interferes with the phosphorylation of pRB, which leads to the 
prevention of progression of the cell cycle. One such CDKl is p16, which acts on CDK4 
and CDK6. Previous studies show that introduction of p16 induces replicative 
senescence in fibroblasts and immortal cells without p53 activity (McConnell et al., 
1998). Further, pRB is required for growth suppression driven by p16 expression. In 
certain cell types, including tumor-derived cells, p16 can be inactivated by methylation 
of its promoter, which renders the pRB pathway inactive as it is continuously 
phosphorylated. 
pRB phosphorylation can also be inhibited by p21, another cyclin dependent kinase 
inhibitor, which has also been shown to be induced during senescence. Several groups 
have found that p21 levels increase prior to p16 levels, leading to the conclusion that 
p21 possibly triggers senescence prior to p16 (Dulic et al., 2000). It has also been 
shown that p16 levels remain high over time in senescent cells, while p21 levels 
decrease after a short period of time (Stein and Dulic, 1998). Even so, p21 appears 
necessary for the induction of cellular senescence, while p16 may be required to 
maintain the senescent phenotype. 
Taken together, p53 appears to recognize and be activated by DNA damage, including 
shortened telomeres (depicted in Figure 3). Following this activation, p53 is able to 
activate the cyclin dependent kinase inhibitors p16 and p21, which then inhibit cdk2, 
cdk4, and ckd6. This inhibition of kinase function ultimately prevents the 
phosphorylation of pRB, which is then unable to activate the E2F transcription factors, 
leading to either a pause in the progression of the cell cycle (quiescence) or a complete 
cessation of growth (senescence). While senescence experimentally may be reversible, 
it is generally thought that senescence, whether in tissue culture or in an organism, is 
an irreversible process that is distinct from cell death pathways, including apoptosis. 
Short Telomeres recognized as DNA damage 
P53 activated 
PI6 and p21 activated (Cyclin dependent kinase inhibitors) 
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Figure 3. Shortened Telomere Response. Shortened telomeres may be recognized 
as DNA damage, activating p53, which either directly or indirectly activates the p16 and 
p21 CDK inhibitors. These CDKl's block cyclins and cyclin dependent kinases, which 
are then unable to phosphorylate pRB, thereby blocking E2FIDP's function in promoting 
the transition from G I  to S phase of the cell cycle. 
The process of cellular immortalization has been the subject of intense study in 
elucidating insight into the development of neoplasia. Cell lines have been transfected 
or infected with viral oncogenes and studied for their ability to bypass or circumnavigate 
the senescence phenotype. These cells generally live longer, have an extended 
lifespan, and eventually enter a stage referred to as crisis. Cells that enter the crisis 
stage following rapid proliferation are generally marked by genomic instability, 
aneuploidy, and significant telomere shortening or dysfunction. During this crisis stage, 
some cells may enter apoptosis, and in fact, the vast majority of the cells undergo some 
sort of cell death pathway (Reviewed by Holt and Shay, 1999). The rare cell or cells 
that escape crisis are considered immortal and generally have activated some type of 
telomere maintenance pathway, which in the vast majority of cells, is the reactivation of 
telomerase enzyme to maintain telomere structure and function (Reviewed by Holt and 
Shay, 1999). Several groups have demonstrated that telomere maintenance is a critical 
step in immortalization and cancer development. These immortal cells also generally 
are found to express one or more oncogenes, as well as require the continuous 
inactivion of tumor suppressor genes such as p53 and pRB (Wright and Shay, 1992). 
Chapter 3 
Telomere Model Systems 
A number of eukaryotic model systems have been used for the study of telomere 
function, aging and senescence. These models systems include tissue culture, such as 
human primary fibroblasts and epithelial cells, complex vertebrate models, and single 
celled organisms such as yeast. 
The telomeres of most organisms' chromosomes consist of short asymmetric repeated 
sequences with lengths varying greatly across different species. Vertebrates tend to 
share the common hexameric telomeric sequence, TTAGGG, while other organisms 
have different telomeric repeats as shown in Figure 4. Humans have as many as 
thousands of TTAGGG repeats per telomere, while holotrichous ciliates such as 
Tetrahymena have approximately 50 repeats per telomere. Arabidopsis (plants) 
telomeres have less than 350 repeats, and Saccharomyces cerevisiae telomeres have 
repeats that stretch between 300 to 500 base pairs in length (Lundblad and Blackburn, 
19993). Drosophila melanogaster chromosomes have transposable elements at the 
end of one of its chromosomes, making the study of the regulation of repeated 
telomere-like elements, especially related to aging, difficult in this organism, not to 
mention the fact that fruit fly and worm (Caenorhabditis elegans) cells are generally 
postmitotic in the adult organism (Holt and Shay, 1999; McChesney et al., 2005). 
Figure 4. A comparison of Telomere sequences. Varying telomere sequences 
among different species, illustrating significant conservation of telomere species among 
very divergent organisms. Note that all vertebrates have the same hexmeric repeated 
sequence: TTAGGG. 
Gallus gallus (chicken) TTAGGG 
Oxytrichia, Euplotes (ciliates) TTTTGGGG 
Trypanosoma, Leishmania (parasites) TAGGG 
Physarum (fungus) 
Saccharomyces cerevisiae (yeast) 
TAGGG 
TGI-~TG*-~ 
Danio rerio, Orizyas latipes (fish) TTAGGG 
Homo sapiens (humans) 
Caenorhabditis elegans (worms) 
TTAGGG 
TTAGGG 
Drosophila melanogaster (fruit fly) transposable element 
Kluyveromyces lactis (yeast strain) ACGGATTTGATTAGGTATGTGGTGT 
- 
Chicken telomeres, on the other hand, are of the TTAGGG variety, and they can be 
classified in three classes, with repeat lengths varying greatly between classes. Many 
studies comparing human and mouse telomeres have been performed. Mouse 
telomeres are tens of kilobases long; whereas humans have been shown to be much 
shorter, in the 10-20 kilobase pair range. A mouse line deleted for telomerase can 
survive for nearly 6 generations without exhibiting any serious genetic or phenotypic 
problems. Failures in meiosis and other problems emerge in the 6th generation when 
telomeres have gotten very short, and the major issue is that the mice are sterile 
(Blasco et al., 1997; Lee et al., 1998). 
In Tetrahymena, the sequence is TTGGGG. Tetrahymena telomeres have 
approximately 50 repeats of this sequence compared to the many thousands of repeats 
in humans and other organisms (Reviewed by Blackburn, 1999). In Sacchaormyces, it 
is a more variable TG1-3 repeat and a much smaller length (300-400 basepairs), nearly 
200-fold less than inbred strains of mice and 50-fold less than humans. 
Yeast cells, deleted for telomerase, slowly lose telomere sequences at a rate of about 
10 base pairs per generation. After 50 generations, yeast cells begin to die as their 
telomeres become too short and cells begin to senesce (Lundblad and Blackburn, 
1993). Another yeast, Kluyveromyces lactis, has a long, 25 basepair repeat sequence 
(Blackburn, 1999). Drosophila does not have repetitive telomeric elements, but instead 
their chromosome ends typically have a transposable element, such as HeT-A, at the 
ends of their chromosome. HeT-A serves as buffer between the chromosome ends and 
active euchromatic regions, but does not provide a similar mechanistic model for 
studying telomere structure and function that would translate to eukaryotic systems. 
Yeast cells, when lacking telomerase, are able to survive by a similar strategy to the 
Drosophila system of retrotransposons: the addition of Y' elements (which may once 
have been transposable elements) to chromosome ends via homologous recombination 
events. 
The telomeres of most mammals contain anywhere from less than 1 to over 50 kilobase 
pairs of telomeric DNA. Human telomeres, as stated above, range between 4 and 20 
kilobase pairs, depending on the cell of origin. Telomeres from germline cells are 
usually 10-20 kilobase pairs, but telomeres are found to be shorter in somatic cells 
because of the inability of somatic cells to maintain telomere lengths (end replication 
problem). Germ- and stem cells have a telomere maintenance mechanism: telomerase, 
which will be discussed in the next chapter (Chapter 4). Interestingly, many forms of 
- cancer exhibit cells with significantly shorter telomeres, and the reason for this is the 
significant cell divisions during the extended lifespan phase. Somatic cells lacking 
telomerase continue to shorten their telomeres while progressing past the senescence 
.- state and to the crisis stage, and in some cases, chromosomes will have severely 
shortened or undetectable telomere lengths. It is these cells that immortalize and 
stabilize their telomere lengths using telomerase. Importantly, there is not a rapid and 
significant elongation of telomere lengths but rather a stabilization of the length, which is 
the reason that most human cancers have shorter telomeres than surrounding normal 
cells (Reviewed in Holt and Shay, 1999). 
Inbred strains of laboratory mice have telomeres that are quite often more than 50 
kilobase pairs long, are heterogeneous in size, and exhibit differences from cell to cell 
and from strain to strain (Reviewed by Rodier et al., 2005). Two different species of 
mice, the inbred strain of Mus musculus and the outbred or wild strain of Mus spretus, 
have as much as a three-fold difference in telomere length (Rodier et al., 2005). Even 
with such significant differences in size, the lifespans of these two species of mouse are 
comparable, which suggests that telomere length, especially in the laboratory inbred 
strains, does not significantly contribute to aging in the mouse. Because of these long 
telomeres and their inability to relate to the mouse lifespan, inbred mice make a poor 
model for the study of telomere shortening as it relates to the aging process. 
The study of telomere structure has revealed a variety of interesting findings. Human 
and mouse telomeres both "exhibit chromatin structures with arrays of nucleosomes 
that have a shorter repeat size than standard heterochromatic nucleosomes" 
(Tommerup et al., 2004). This observation would further strengthen the hypothesis that 
genes near the telomeres are subject to transcriptional silencing from position effects 
and progressive telomere shortening. Telomere specific proteins are also .found 
associated with chromosome ends and are discussed in more detail below. The 
structure of chromatin at telomeres is unusual. There are several telomere sequence- 
specific telomere binding proteins (in mammals, TRFI and TRF2, among others which 
are further discussed below) that help protect the DNA ends from degradation and 
presumably contribute to the specific heterochromatin associated with the telomere. 
Specific understanding of the interaction between the telomeric DNA, bound proteins 
and tumor suppressor genes (hence, telomere structure) is interesting for many 
reasons. Telomeres have a 3', G-rich overhang, which has been shown to be critically 
important to formation of structures called T-loops. These T-loops are characterized by 
insertion of the G-rich overhang into the double stranded telomere structure (Figure 5), 
although it is not completely understood how the T-loop forms. It is hypothesized that 
the 3' overhang binds to the complementary C-rich strand at the point of displacement. 
The telomere binding protein TRF2 (telomere repeat binding factor 2) has been shown 
to modulate the formation of the T-loop structure, while the POT1 protein helps to 
maintain the structure and also to protect the 3' overhang from being degraded (Figure 
5). There is substantial evidence that many organisms form T-loops to protect the 
exposed 3' end of the chromosome. The 'T-loop' complex is believed to loop back on 
the double stranded telomeric DNA, which was initially observed with electron 
microscopy by Griffith et al. (1999). The looping back of the single stranded overhang 
possibly explains how the single stranded sequence is not recognized by DNA damage 
sensory proteins and subjected to repair machinery. Another possible explanation for 
the lack of DNA repair in response to single stranded DNA ends is the association of the 
other telomere binding proteins, such as POT1 (protection of telomeres 1). In either 
case, it is believed that the associated proteins are vital to this protection, either 
facilitating the formation of the t-loop of simply protecting the single stranded DNA. 
Figure 5. Hypothesized telomere associated protein binding and T-loop structure. 
(From Rodier et al., 2005). It is hypothesized that the telomere ends are stabilized by a 
variety of factors including TRFl and TRF2, and that TRF2 is able to mediate the 
invasion of the 3' single stranded overhang into the duplex telomeric DNA to form the T- 
loop. It further thought that the invaded single stranded 3' overhang is stabilized by the 
POT1 protein. This structure prevents telomeres from being recognized as damaged 
DNA, provided the proper stability to the chromosome ends. 
Additional proteins are thought to be associated with the telomere as illustrated in 
Figure 5. TRFI is believed to inhibit telomerase access to the telomere (Karlseder, 
2003), while also serving to preserve telomere integrity and structure. TRF2 has been 
shown to be essential for the formation of the T-loop and also for preservation of 
telomere structure and function. Disruption of TRF2 binding has been demonstrated to 
cause a loss of the G-strand overhang causing telomeric fusions and anaphase bridges 
(Karlseder et al., 1999). Loss of TRF2 in human primary fibroblasts was shown to elicit 
a senescent phenotype, which is p53 or pRB dependent (Smogorzewska and de Lange, 
2002). Thus, maintenance of telomere structure and function in normal human cells is 
critical for prevention of cellular senescence and disruption of the delicate telomere 
balance can lead to either a gradual induction of senescence if not overtly severe or an 
immediate premature senescence phenotype. 
Chapter 4 
Telomerase 
The first telomerase to be discovered was that of the Tetrahymena thermophila species 
in 1985 by a very driven graduate student in the laboratory of Dr. Elizabeth Blackburn at 
the University of California at San Francisco (Greider and Blackburn, 1985). 
Telomerase is a telomere specific DNA polymerase that is capable of maintaining 
telomeres. It is a ribonucleoprotein that adds telomeric repeats to chromosome ends. 
Telomerase is a protein RNA complex consisting of two subunits, TR and TERT. The 
protein catalytic subunit, or TERT, component was first identified in Euplotes 
aediculatus and contains typical reverse transcriptase motifs (Lingner et al., 1997). TR, 
the RNA component, provides the template for repeat synthesis by the TERT 
polymerase subunit. It has been shown that by mutating the template sequence of the 
RNA component, the sequence of the telomere can be modified (Yu et al., 1990) and in 
some cases, cause rapid elongation or shortening. The TERT (telomerase reverse 
transcriptase) subunit provides the catalytic activity of the enzyme. 
The telomerase RNA subunit varies in size among different organisms. The smallest, 
only 150 base pairs, is found in ciliated protozoan, while mammals have longer TR 
subunits, with the human TR being 451 bases. Curiously, lower eukaryotes like K. lactis 
and S. cerevisiae have TR subunits of approximately 1.3 kilobases for reasons that are 
not completely understood. 
Figure 6. Hypothesized telomerase enzyme interaction with telomere. The 
telomerase enzyme is composed of TR (template RNA, shown with significant 
secondary structure) and TERT (telomerase reverse transcriptase, shown in green) and 
2 proteins that serve to facilitate the folding of the enzyme complex, p23 and hsp90, 
One hypothesis thought is that not only do the hsp90 chaperones serve to stabilize the 
telomerase holoenzyme, they also are critical for its interaction with the telomere. 
Like other reverse transcriptases, telomerase is a ribonucleoprotein consisting of an 
RNA template and a protein catalytic subunit. Across species, the protein subunit is 
highly conserved, while the RNA subunit is much more variable. In humans, the RNA 
component, hTR (human lelomerase RNA), is ubiquitously expressed, while the protein 
component, hTERT (human &lomerase Reverse Lranscriptase), is only expressed in 
cells that activate telomerase activity such as stem cells, germ cells, and activated 
lymphocytes. The role of telomerase is to catalyze the sequential addition of telomeric 
repeats to the lagging strand of DNA in a dividing cell, by reverse transcribing DNA 
complementary to the hTR template. Telomerase works in a processive manner, 
meaning that it synthesizes 6 bases at a time. Once complete, the telomerase complex 
must translocate and synthesize 6 new bases. This process of elongation followed by 
translocation is repeated until the native telomere length is maintained. What makes 
telomerase a processive enzyme is the ability for 1 holoenzyme complex to 
continuously replicate telomere ends, rather than having another complex displace the 
enzyme already bound to the telomere (Figure 7). 
Telomerase activity can be reconstituted in vitro by combining hTERT and hTR 
(Weinrich et al., 1997). These reconstitution assays have been used to study the 
activity of telomerase biochemically. In addition, many studies have identified numerous 
proteins that associate with telomerase, including hsp90 and p23 (Holt et al., 1999; 
Forsythe et al., 2001). The collective telomerase complex is referred to as the 
holoenzyme. This chaperone complex was found to interact directly with hTERT (Holt 
et al., 1999), but unlike other chaperone targets where chaperones were only 
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Figure 7. Telomerase Priming and Telomere Elongation. Telomeres are elongated - 
by telomerase in a processive elongation, translocation, elongation pattern extending 
the lagging strand of the telomere from 5' to 3'. Taken from Harley and Villeponteau, 
1995. 
associated transiently, hsp90 and p23 remain bound to the active telomerase enzyme 
(Forsythe et al., 2001). The reason for this continued association of chaperones may 
have something to do with the telomerase enzyme's processive characteristics, given 
that it polymerizes telomere addition and translocates to the next available position to 
synthesize again. There may be some additional tweaking of enzyme structure or 
conformation that is required for effective and processive replication of telomere 
repeats. Alternatively, a recent hypothesis is that hsp90 and p23, while not specifically 
required for assembly of the complex initially, are necessary for telomerase to bind to 
telomeres (a.k.a. hsp90 and p23 are required for substrate recognition) (Dr. M. 
Jarsterfer, University of North Carolina, Chapel Hill, NC, personal communication). 
Additional required components for a functional telomerase holoenzyme include hsp70, 
HOPIp6O (hsp organizing protein) and hsp40 (Forsythe et al., 2001), all of which are 
necessary for efficient assembly of the TERT and TR components. Recent experiments 
done in the laboratory have suggested, although not proven, that the HOP and hsp40 
components are not strictly required for assembly but serve to accelerate the process 
(Rapp, Elmore, and Holt, unpublished data). 
The RNA subunit, hTR, contains a template that is "used for the priming of DNA 
synthesis by the hTERT subunit. The template within the TR is approximately a 9-11 
bases, and varies between species (Chen et al., 2000). Interestingly, mutations made in 
the hTR template were incorporated into the resulting telomeric DNA following 
transfection of cells with mutated hTR, and even more striking was the finding that 
mutations in the yeast TR in K. lactis causes a fatal telomere elongation, which could be 
the result of the 25 base template sequence and the non-repetitive nature of their 
telomeres (Reviewed by Blackburn, 1999). 
Telomerase Activity 
In mice and humans, telomerase is active primarily during fetal development. 
Telomerase is subsequently turned off in somatic cells around the time of birth, 
presumably during tissue differentiation, and telomeres shorten with every cell 
generation in these cells. Stem cells, such as those in the bone marrow, as well as 
germ cells and activated lymphocytes, are exceptions, as telomerase remains active in 
these cells (Reviewed by Holt and Shay, 1999). Clearly, this activity is necessary to 
avoid premature senescence in highly proliferate cell types and provide regenerative 
capabilities and immunological response throughout the course of life. 
In cancers, telomerase is usually re-activated and seems to be a key step in allowing 
cells to become immortal. As discussed above, immortal cells generally require the 
reactivation of telomerase to continue proliferation and overcome the telomere-induced 
crisis typical of preimmortal cells. Because more than 85% of human malignant cancers 
have telomerase activity (Shay, 1997), telomerase activity can be used as a clinical 
marker in the detection of cancer, although it is unlikely to replace conventional 
pathological determinations. Even so, having such a prominent molecular marker 
should provide an additional tool for those cases that are difficult to diagnose and may 
provide some suggestive evidence for prognosis as well. However, the level and 
distribution of telomerase activity has still not been proven to be a 100% reliable tool for 
diagnosis and prognosis of cancers (Reviewed in Holt and Shay, 1999). As telomerase 
activity is not found in all cancers, it is not required for tumorgenesis; yet, without a 
mechanism for telomere length maintenance, the cells will be susceptible to 
senescence. What this means is that certain cancer types may be mortal, having long 
telomeres and no need for a telomere maintenance mechanism. In addition, the 
traditionally used "85%" number is likely artificially low given the number of laboratories 
that have contributed to this figure and the variability in sample handling and 
processing, as well as the inability (at least in the beginning) to distinguish true 
negatives from false negatives. When the PCR-based telomere repeat amplification 
protocol (TRAP assay) was first developed, there was no positive control for PCR 
amplification and truly negative samples could not be easily distinguished from those 
that had PCR or Taq polymerase inhibitors in the samples. Certainly, there were ways 
to handle that, like mixing experiments or phenol/chloroform extractions to remove the 
inhibitors, but it was not until the advent of an internal PCR standard that the numbers 
could be accurately counted. As such, the number that should be used to telomerase 
activity in cancers is more accurately expressed as "over 90% of all human cancers" 
and advanced malignancies likely express telomerase around 99% of the time. Thus, 
unless a mortal tumor, telomeres in cancer cells-are generally observed to undergo no 
net loss of telomere length, suggesting that either telomerase is active or the minor ALT, 
recombination-based pathway for telomere length has been activated in these cells. 
Introduction of telomerase into normal cell lines has been shown to increase population 
doublings significantly, more than triple their normal lifespans (Bodnar et al., 1998; Holt 
and Shay, 1999). Further, these cells were found to be "indistinguishable" from younger 
cells of the same lineage (Holt and Shay, 1999). Several groups have studied the effect 
of introducing telomerase into normal cells, and in each of these studies, it was 
suggested that while telomerase activity extends the possible population doublings, this 
activity alone is not sufficient for cancer development (Reviewed in Holt and Shay, 
1999). 
Some cell types exhibit telomerase activity even though their telomeres continue to 
shorten. This was the subject of investigation in a seminal paper by Masutomi and 
colleagues (2003)' where telomerase was shown to maintain telomere structure in 
normal cells that have long been thought to lack any telomerase expression. Following 
observations that telomere length, structure, and telomerase activity's effects on 
replicative lifespan and senescence appear correlative rather than directly related, they 
sought to identify a specific relationship between these elements (Masutomi et al., 
2003). Based on the observation of telomere shortening and telomerase activity in 
keratinocytes, lymphocytes and some hematopoetic progenitor cells, a study was 
designed to understand the physiologic purpose of telomerase activity in these cells. 
Using two inhibition systems, a dominant negative hTERT (DN-hTERT) or a hTERT 
shRNA (short hairpin RNA), they observed that when telomerase activity was blocked in 
normal human fibroblast cell lines, the cell's entry into S phase was delayed and an 
accumulation of cells in the G2lM phase occurred (Masutomi et al., 2003). Cell death 
was not observed in these cells, yet they observed that cell cycle progression in these 
cells was delayed and continued to proliferate for "many" population doublings. They 
concluded that these observations indicate that telomerase activity in these cells was 
necessary for cell cycle progression of normal cells. Further, they observed that cells 
with the DN-hTERT mutant had a 50% reduction in population doublings when 
compared to controls. When observed following cell division, the DN-hTERT infected 
cells appeared "vacuolated and flattened" compared to normal controls and failed to 
become confluent in culture even after many weeks. Further investigation indicated that 
the cells expressing the DN-hTERT entered replicative senescence sooner than 
controls. These studies indicate that inhibiting hTERT activity in these normal cells 
prematurely initiates senescence. 
The authors further conclude, "the regulation of hTERT and telomerase is a dynamic 
process even in normal human cells and suggest that active maintenance of the 
telomere is necessary for the proliferation of normal human cells" (Masutomi et al., 
2003). Using cell sorting and cell synchronization, the authors were able to find 
telomerase activity expressed during the S phase of the cell cycle, using TRAP and 
immunofluorescence with an hTERT antibody generated in their laboratory. Their 
findings also suggest that there is physiologic expression of hTERT in "most if not all 
human cells as they pass thr0ugh.S phase", although they only showed it for a handful - 
of cell strains. They conclude that inhibition of telomerase function during S phase 
somehow interferes with its role in stabilizing the 3' telomeric overhang, and loss of the 
3' overhang is strongly correlated with entry into senescence. 
As has previously been discussed, it has been shown by multiple groups that telomere 
shortening is also associated with the initiation of cellular senescence and may be 
correlated with the loss of the 3' overhang (Masutomi et al., 2003). To identify a 
correlation between the telomerase inhibition in these cells and telomere shortening, 
telomere length was examined. They did not observe a difference between telomere 
lengths in control or telomerase inhibited cells. An analysis of the integrity of the 3' 
overhang in the telomerase-inhibited cells was also conducted. When observed around 
18 population doublings, they observed a significant reduction in the amount of 3' 
telomeric overhang DNA (Masutomi et al., 2003). From all of these experiments, they 
conclude, "modulated telomerase activity is involved in the regulation of the cell cycle, 
cell proliferation, and lifespan" (Masutomi et al., 2003). What is curious about all of this 
work is that this is the only group to have shown this, and they use cell strains that have 
been consistently used by a number of groups, including our own, for over a decade. 
While the data presented is clear, if not somewhat overstated, there remains serious 
doubt about the reality of the expression of telomerase (specifically hTERT) in normal 
human cell strains. 
The ALT Pathway 
As previously mentioned, some immortal cells are able to maintain telomere length in 
the absence of telomerase activity. In fibroblasts immortalized by transfection of SV40 
Large T-antigen, the ALT pathway is present a significant amount of the time (Reviewed 
by Bechter et al., 2004). In these cells, the ALT pathway is generally indirectly identified 
by the absence of telomerase activity and telomeres are found to have a wide variety of 
mostly heterogeneous lengths. It is hypothesized that the ALT pathway is enabled by a 
homologous recombination mechanism. Bechter et al. (2004) found that in cells 
maintaining telomerase length via the ALT pathway, homologous recombination 
occurred in equal amounts to cells with telomerase activity. These recombination 
events appear to occur in the telomeric repeat regions rather than sub-telomeric 
regions. Bechter et al. (2004) discuss a model whereby "elongation in ALT cells 
involves a break-induced replication", which is hypothesized to be marked by invasion 
of a critically short telomere into a donor telomere via homologous recombination 
leading to "nonreciprocal transfer of DNA onto the shorter telomere". Fewer 
recombination events appear to occur in telomeric regions containing non-conical 
sequence variants, which are possibly binding sites for telomere binding factors 
necessary for recombination inhibition (Bechter et al., 2004). Further investigation into 
specific factors involved in the ALT pathway could lead to potential therapeutic methods 
for cancer treatment. 
The ALT pathway has been well studied in yeast, where telomerase is constitutively 
expressed. Generally, yeast cells have been shown to enter senescence following 
mutation of the telomerase-genes. In yeast cells without active telomerase, senescence 
usually occurs after 70 cell divisions, except when the ALT pathway is activated 
(Lundblad and Blackburn, 1993). Yeast cells have been shown to have two types of 
ALT pathways, type I and type II, both of which use recombination mechanisms to 
maintain telomere length (Teng and Zakian, 1999). Type I and type II ALT pathways are 
differentiated by the repeated sequence, where type I repeats in yeast are marked by 
the repeated Y elements, while type II telomeres have vast arrays of TGI-3 repeats. 
Overall, the ALT pathway appears to be a minor cancer pathway, and only a single 
study has shown that recovery after telomerase inhibition occurs as a result of the 
activation of the ALT pathway (Bechter et al., 2004). This manuscript shows that a 
mutation in the mismatch repair gene, MSHG, is the only way that recovery by ALT can 
occur, and the mutation frequency of mismatch repair genes is generally extremely low. 
Thus, in terms of cancer development, the ALT pathway is minor compared to the 
telomerase pathway; even so, studies on ALT will be important for defining additional 
mechanisms for telomere-based therapeutic interventions. 
Telomerase Gene Regulation 
Transcriptional regulation of the TERT gene is believed to be the critical control of 
telomerase expression as the RNA subunit is generally ubiquitously expressed (Bodnar 
et al., 1998; Cong et al., 2002). The core of hTERT gene promoter is a 330 base pair 
sequence upstream of the translation start site. The maximum promoter activity was 
mapped to a 59 base pair region between -208 and--1 50 (Horikawa et al., 1999). The 
hTERT promoter does not contain a TATA or CAAT box (Horikawa et al., 1999). The 
promoter is GC rich, which is consistent with methylation-based regulation (Horikawa, 
1999). The E-box, characterized by the sequence CACGTG, which is activated by the 
bHLHZ family of transcription factors, was identified to be vital to hTERT transcription 
and that c-Myc expression increases the transcriptional activity of this box (Horikawa et 
al., 1999). Direct binding of a c-MycIMax heterodimer was demonstrated by Xu et al 
(2001). Upregulation of the hTERT gene by c-myc is consistent with the activation of c- 
myc by mutant p53 and other viral oncoproteins. 
Binding sites for Spl and MAZ are found in the hTERT promoter as well (Kyo, 2000). 
Spl binds the GC-boxes thought to be important for transcriptional initiation. These 
Spl binding sites are required for transcriptional activity of the hTERT gene (Kyo et al., 
2000). Klingelhutz identified the human papillomavirus 16 E6 as an activator of hTERT 
transcription (Klingelhutz et al., 1996), which may actually serve to derepress hTERT by 
inactivation of p53 (discussed more below). Another interesting observation of 
telomerase transcription in endometrial tissue suggests that sex hormones are possibly 
involved in the regulation of telomerase activity (Reviewed by Cong et al., 2002). The 
hTERT promoter does have an estrogen receptor element (ERE), although significantly 
upstream of the core promoter, but the ERE is thought to be activated when endometrial 
tissue is proliferating (Kyo et al., 1999). 
As telomerase is not expressed in most human somatic cells, the repression of 
telomerase transcription is of particular interest. Two independent laboratories showed 
a series of experiments where specific chromosomes from normal human cells were 
transferred to telomerase-expressing cells demonstrated a likely repressor of hTERT 
expression (Oshimura et al., 1995; Nishimoto et al., 2001). Oshimura and colleagues 
suggest that, after microcell-mediated transfer of chromosome 3 in renal cell carcinoma, 
there is a repressor of telomerase on the p arm of chromosome 3 (Oshimura et al., 
1995). Nishimoto also demonstrated that transfer of chromosome 10 into telomerase- 
positive human hepatocellular carcinoma cells caused a repression of telomerase 
activity and eventual telomere shortening (Nishimoto et al., 2001). These findings have 
lead to additional studies to identify specific factors that repress hTERT transcription. 
One case of repression of hTERT transcription involves the competitive inhibition of 
expression through the E-box, which is bound by the c-MycIMax heterodimer. Madl, a 
member of the Mad family of proteins known for being negative repressors of cell 
growth, is found to repress telomerase expression when found as a heterodimer with 
Max (Xu et al., 2001). Mad1 had previously been shown to negatively repress cell cycle 
progression and to repress other genes controlled by E-boxes in their promoters 
(Reviewed by Xu et al., 2001). 
Repression of hTERT transcription by p53 has been demonstrated by Kanaya et al. 
(2000). These studies demonstrate that repression of telomerase expression through 
transfection of p53 preceded cell growth inhibition and apoptosis typically induced by 
p53 over expression (Kanaya et al., 2000). They found that the transcriptional 
repression of hTERT by p53 over expression was dependent upon the upstream Spl  
binding sites in the hTERT promoter (Kanaya et al., 2000). Additional negative effectors 
of telomerase transcription include pRB, E2F, Wilms' tumor 1 tumor suppressor, and 
myeloid cell-specific zinc finger protein 2 (Reviewed by Cong et al., 2002). 
The post-translational modification of telomerase is also considered a significant 
mechanism for telomerase regulation. The phosphorylation of the telomerase catalytic 
subunit appears to play the most important role in posttranslational modification of 
telomerase. Through phosphatase treatment of nuclear extracts, telomerase activity is 
down-regulated, while kinase treatment of nuclear extracts leads to increased 
telomerase activity (Bodnar et al., 1996). In vivo experiments have shown that tyrosine 
kinase c-Abl phosphorylates hTERT leading to down-regulation of telomerase activity in 
contrast to the in vitro results discussed above (Reviewed in Cong et al., 2002). There 
are numerous studies related to potential phosphorylation pathways involved in hTERT 
regulation, most of which are indirect and fail to provide the critical data or experiments 
that conclusively show regulation of telomerase via post-translational modification. As 
such, they will not be discussed for this literature review. 
Chapter 5 
Phylogenetic Analysis of Telomerase Subunits 
The subunits of telomerase have been cloned in a number of organisms. The following 
discussion will focus on the cloning, homology, and structure of known TERT and TR 
homologs. 
The Functional Telomerase RNA Component 
Telomerase RNA subunits (hTR in humans) have been identified in many organisms. 
These include 24 ciliates, two yeast, mouse, cow and human (Chen, et.al. 2000), as 
well as 32 new telomerase RNA genes cloned by Greider's group (Chen et al., 2000). 
They cloned 18 different mammals, 2 birds, 1 reptile, 7 amphibians, and 4 different fish 
species. There is quite a bit of heterogeneity in the size and sequence of the identified 
genes in the Telomerase RNA subunit family, but there is also significant sequence 
homology in critical structural domains. 
Phylogenetic analysis of these genes was performed, and eight conserved regions, 
notated CRI-CR8, were identified in these genes. A conserved region was identified 
when base pairs shared 90% or greater homology. The first conserved region 
represented the template region, critical for telomere elongation, with a consensus 
sequence of 5'-CUAACCCU-3'. CR-1 is 45 nucleotides downstream of the 5' end of the 
human gene. Interestingly, the mouse and other rodent genes only contain two 
nucleotides of sequence upstream of CR-I. Mammals with larger sequences upstream 
of the first conserved region contain transcriptional promoter sites including a CCAAT 
and TATA site, suggesting that the TR gene is an RNA polymerase II transcript even 
though it is not an mRNA. There is some controversy over whether this is true, but given 
that most mRNAs code for proteins, it is unusual that a functional RNA like TR could be 
an RNA polymerase II transcript. 
CR-2 is one of two longer conserved regions, along with CR-5, with an approximately 
25 base region of homology that was useful as an anchor point in analysis and 
degenerate primer design for PCR amplification and subsequent cloning of the TR 
genes. The other conserved regions, 3, 4, 6, and 7 are shorter regions of conservation 
and are critical for the formation of TR's secondary structure. 
The following species telomerase RNA subunits were cloned; Class Mammalia includes 
Homo sapiens (Human), Trichechus manatus (Manatee), Elephas maximus (Elephant), 
Dasypus novemcinctus (Armadillo), Oryctolagus cuniculus (Rabbit), Tupaia glis 
belangeri (Treeshrew), Chinchilla brevicaudata (Chinchilla), Cavia porcellus (Guinea 
Pig), Equus caballus (Horse), Bos taurus (Cow), Sus scrofa (Pig), Felis catus (Cat), 
Procyon lotor (Raccoon), Mustela putorius furo (Ferret), Suncus murinus (Shrew), 
Geomys breviceps (Gopher), Microtus ochrogaster (Vole), Cricetulus griseus (Hamster), 
Mus musculus (Mouse), Raffus norvegicus (Rat), and Dasyurus hallucatus (Quol I). 
Class Aves includes Gallus gallus (Chicken) and Anodorhynchus hyacinthinus (Macaw). 
Class Reptilia includes Chelydra serpentina (Turtle). Class Amphibia includes Xenopus 
laevis (Xenopus), Bombina japonica (Toad), Ceratophrys ornata (Horned Frog), 
Pyxicephalus adspersus (Bullfrog), Dermophis mexicanus (Dermophis), Herpele 
squalostoma (Herpele), and Typhlonectes natans (Typhlonectes). Class 
C hondrichthyes includes Dasyatis sabina (Stingray), Rhinoptera bonasus (Cownose 
Ray), Rhizoprionodon porosus (S harpnose Shark), and Mustelus canis (Dogfish Shark). 
The telomerase RNA subunit's secondary structure is critical in its interaction with the 
catalytic subunit, TERT, and the telomere. The secondary structure of the RNA subunit 
has been looked at by a variety of groups, but it is believed that nucleotides that interact 
in secondary confirmations will evolve while maintaining Watson-Crick pairing capability, 
a phenomena referred to as co-variation (Chen et al, 2000) (Figure 8). As such, the 
telomerase RNA subunit genes sequences are able to maintain their helical secondary 
structures. Even with different bases, the predicted secondary structures are 
maintained due to conserved base pairing within the conserved regions of the transcribe 
RNA component. 
Chen and colleagues (2000) identified eight paired regions, separated by junction 
regions (Figure 8). P I  is 5' of CR-1 and pairs with a region downstream of CR-3. P2 
has two regions, P2a and P2b, separated by junction 2, which pairs with a region just - 
downstream of CR-2. P3 is within CR-2 and pairs with a region within CR-3. P4 is 
downstream of CR-3 and just upstream from the 5' hyper variable paired region. The 
hyper variable regions are extremely heterogeneous across species. The upstream 
hyper variable region pairs with a region just downstream of CR-5. P4 pairs with a 
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Figure 8. Hypothesized hTR structure. hTR is believed to form a complex secondary 
structure including several stem loops. This structure is conserved among a variety of 
very divergent species, illustrating the importance of this complex structure. Taken from 
Chen et al., 2000. 
region in CR-6. P5 is just upstream of CR-4 and pairs with a region at the 3' end of CR- 
5. P6 is in CR-4 and pairs with the 5' region of CR-5. P7 is just downstream of CR-6 
and pairs with a region 5' of CR-8 while P8 is just upstream of CR-7 and pairs with 
bases just downstream of CR7. All of this pairing creates a rather complex secondary 
structure with a variety of helices as is illustrated in Figure 8. 
Chen proposes 4 distinct domains in vertebrates, including the Pseudoknot domain, the 
CR-41-5 Domain, the CR-7 Domain and the Box HIACA Domain. The Box HIACA 
Domain is similar to the Box H and Box ACA seen in snoRNA's (Reviewed in Chen et 
al., 2000). It is believed that the HIACA region is necessary in vertebrates for 3' end 
processing of the RNA (Ganot et al., 1997; reviewed by Chen et al., 1999). This region 
is not found in lower eukaryotes (Reviewed by Cong et al., 2002). The CR-7 domain 
contains two helices, as does the CR-41-5 domain. The Pseudoknot contains the CR-2 
and CR-3 regions, helices and the single stranded template region. The Pseudoknot is 
conserved in ciliates as well as vertebrate species. The Pseudoknot has been shown to 
be essential for assembly of telomerase in ciliates and is required for the function of 
human telomerase (Gilley and Blackburn, 1999). Although a rather complicated 
secondary structure, the sequence and homology of the TR transcript is highly 
conserved among a wide variety of species, from human to lower eukaryotes. 
TERT structure and binding 
The TERT enzyme structure has been closely studied. The hTERT gene is located on 
chromosome 5, on the p-arm. It is 40 kilobases in length and consists of 16 exons 
Figure 9). hTERT is located or~ly 2 megabases from the telomere, opening the 
possibility of a position effect, where reversibility silences genes proximal to telomeres. 
It is not clear if the effect can span the approximately 2 MB between the hTERT gene 
and the telomere (Cong et al., 2002). The proximity of the hTERT gene to the telomere 
raises the intriguing possibility 'that in successive generations of daughter cells, 
progressively shorter telomeres bring the hTERT gene closer to the end of the 
chromosome, allowing a position effect to play a role as cells age. 
There are severally differentially spliced hTERT transcripts (Cong et al., 2002). These 
different transcripts are expressed in a "tissue-dependent and gestational-age 
dependent manner" (Cong et al., 2002), and only the full length hTERT transcript is 
found as a protein in cells. A possible dominant negative function of the splice variants 
was observed in a study by Colgin et al. (2000), but may serve as a dominant negative 
by preventing transcription of the less prominent wild-type mRNA. 
The primary catalytic domain is more than a third of the protein. This domain is 
characterized by a series of reverse transcriptase motifs that catalyze the synthesis of 
-. telomeric repeats. A variety of organisms that have been studied shared homology in 
this centrally located region of the TERT protein, as well as other reverse transcriptases 
from viral origins. The C-terminus is quite divergent, with yeast and human sequences 
sharing almost no similarities in sequence or function. Overall, the TERT genes from 
various organisms are phylogenetically conserved, though they share more homology 
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Figure 9. hTERT Genomic Structure. The hTERT gene is located on the p arm of 
chromosome 5. It includes 16 exons as well as TI ,  T2 and A, 9, C, D, and E reverse 
transcriptase motifs. 
with themselves than they do with other reverse transcriptase genes (Reviewed by 
Cong et al., 2002). 
The N terminus of the telomerase gene has four domains termed I, 11, Ill, and the T- 
motif. Several groups have shown that these domains are essential for yeast viability 
(Lingner et al., 1997). Domain Ill and T-motif are necessary for TERT's ability to 
associate with the RNA subunit (Bryan et al., 2000). Telomerase activity can be 
abolished by deleting the first 350 amino acids in human TERT (Reviewed in 
Armbruster et al., 2001). Alignments of approximately 500 amino acids of the N 
terminus of several TERT proteins from different organisms "identified 5 identical 
residues, clustering in three regions termed GQ, CP, and QFP, which overlap with yeast 
domains I, II, and Ill, respectively'' (Armbruster et al., 2001). It appears that 
evolutionarily conserved regions of the TERT gene are essential for RNA binding and 
telomerase activity (Reviewed in Armbruster et al., 2001 ). Experiments in Tetrahymena 
also demonstrated that the N-terminus is required for enzymatic. activity, namely the T- 
motif and domains II and Ill (Lai et al., 2001). The N-terminus has also been shown to 
be required for interaction with hTR (Bachand and Autexier, 2001 ). 
Chapter 6 
Model Systems for the study of Cancer and Aging 
The search for effective model systems for the study of cancer and aging has included 
the use of a number of in vitro and in vivo systems. A variety of tissue culture, 
mammalian, and non-mammalian vertebrate model systems have been used to study 
cancer and aging, and many new model systems are actively being developed. Each 
system has its own limitations, some of which will be discussed and compared in this 
chapter. 
With regard to the mouse as a model for the role of telomerase in cancer and aging, 
unique mouse genomic characteristics affect the value of it as an effective model 
system. As described above, mouse telomeres are extremely long, with lengths ranging 
from 50 to 100 kilobases in length, making it relatively impractical to study the effect of 
telomere shortening in mouse aging in a single generation. As such, we will discuss 
alternative models that could be used to study telomere biogenesis and telomerase 
regulation during the aging process. 
Mouse Knockout 
The mouse knockout experiments illustrate some of the challenges of the mouse as a 
model system for human telomere biology. Mice have been created with the mouse 
homolog of hTR, the mTR gene, knocked out. These mice were shown to be viable for 
at least six generations (Blasco et al., 1997), even though cells from these mice had no 
measurable telomerase activity following approximately 300 population doublings. 
Telomere shortening was observed in these animals. Blasco and colleagues observed 
that telomeres shortened approximately 5 kilobases per generation (Blasco et al., 
1997). After 5 generations, the average telomere distributions ranged from no 
measurable telomere to telomeres of 50 kilobases in length. Because inbred strains of 
mice have telomeres with lengths averaging between 30 and 80 kilobase pairs, there 
was no discernible phenotype for 6 generations. 
Further, Blasco et al. (1997) observed that mouse embryonic fibroblast (MEF) cultured 
from the telomerase knockout mice have similar growth and senescence patterns as 
wild-type mice. Some cells were observed to grow for more than 200 population 
doublings without telomerase activity. Additionally, nude mice developed tumors after 
implantation of telomerase knockout embryonic fibroblasts, which had been transformed 
by oncogenes, suggesting that telomere lengths were sufficient to produce tumors in the 
absence of telomerase activity. 
The telomeres of the telomerase knockout mice were shown to shorten approximately 
100 bases per cell division. Because of the dramatically larger mouse telomeres as 
compared to humans, the shortening of mouse telomeres in the telomerase knockout 
mouse does not directly lead to cell cycle instability. The large mouse telomeres 
provide critical subtelomeric regions with substantial protection. Blasco et al. (1997) 
observed a higher frequency of karyotype abnormalities after 6 generations of breeding 
of telomerase knockout mice compared to earlier generations, including aneuploidy and 
end-to-end fusions. 
As evidenced from the mouse knockout experiments, researchers must be prepared to 
invest significant time and resources to study the cumulative effects of these alterations 
to mouse aging and cancer in many generations. With telomerase activity not required 
for the maintenance of telomere length in tumorigenesis, and as the mouse telomeres 
are able to protect mouse chromosomes from de novo changes that cause telomere 
erosion, the mouse is not an effective model for understanding telomere shortening and 
its related pathology in order to gain insight into human cancer and aging. An effective 
model for the study of telomerase inhibition and telomere shortening with a closer 
relationship to human biology is still being sought, and some suggestions are listed 
below. 
Fish Models 
A variety of fish have been looked at as potential model systems for the study of cancer 
and aging. Fish species such as zebrafish, Japanese medaka, minnows, guppy, trout 
and others have been studied. It has been demonstrated that fish cancers share similar - 
structure and development to humans (Reviewed in McChesney et al., 2005). Further, 
response to knockdown of the p53 tumor suppressor gene in zebrafish caused a 
change in apoptotic response following the induction of DNA damage (Reviewed in 
McChesney et al., 2005). 
Work conducted by the Holt laboratory has demonstrated that telomerase is present in 
the majority of fish tissues in a variety of marine species. Telomerase was also shown 
to be expressed in American eel, zebrafish, medaka, dog.fish shark, flounder, as well as 
marine invertebrates such as sea cucumber, green sea crab and lobster (Reviewed in 
McChesney et al., 2005). Further, this work has demonstrated that fish telomere 
lengths are consistent with human telomere lengths (McChesney et al., 2005), perhaps 
making fish a better model for telomere studies related to aging and age-related 
diseases such as cancer. 
The Chicken as a model system for the study of aging and cancer 
The chicken, Gallus gallus, is considered one of the premier non-mammalian vertebrate 
models for the study of disease. Though it is considered a critical agricultural 
commodity, seminal scientific breakthroughs have and continue to be made in the 
chicken. Critical findings in embryology and development were made using chicken as 
the model system. The in ovo development of chicken embryos as compared to in 
utero development of mammals provides for a closer examination of development. The 
role of the chicken in the study of immunology has also been pivotal. The distinction 
between B-cells and T-cells was made in the chicken, with B-cells gaining their name 
based on the chicken's Bursa of Fabricius (Cooper et al., 1966). 
The chicken lifespan, up to 30 years, is substantially longer than the average mouse 
lifespan. Also, as described above, chicken telomeres are more similar in size to 
humans than mice. The chicken has three classes of telomere, with Class I ranging 
from 0.5 to 10 kb in size, Class II ranging between 10 to 40 kb in size, and Class Ill 
ranging between 40 kb to 2 Mb in size. The class I and II chicken telomeres are similar 
in length to those of human telomeres at varying stages of life. Primary chicken cell 
cultures are shown to undergo replicative senescence and have low rates of 
spontaneous immortalization (Hay, 1970; Reviewed in Venkatesan and Price, 1998). 
The Chicken genome was sequenced by International Chicken Genome Sequencing 
Consortium in 2004. The chicken chromosomes share similar size heterogeneity to 
chicken telomeres as described above. Chromosome 1 of Chicken is 150 to 200 
megabases in length while 30 of the 38 chicken autosomes are called 
"microchromosomes", with sizes between 5 and 20 megabases. The total size of the 
haploid chicken genome is roughly half the size of the human genome, with 1 . 2 ~ 1 0 ~  
base pairs of DNA. The maintenance of the chicken microchromosomes is interesting 
in researching both genomic stability as well as the creation of artificial chromosome 
models. Importantly, comparative analysis of chicken genes with homologs in mouse 
and human has shown significantly more compact gene sequences in the chicken with 
smaller introns and intergenic regions (Regnier et al., 2003). 
The study of cancer in the chicken has also produced many important findings. The first 
' it~mor virus", ROUS sarcoma, as well as the first oncogene, src, were identified in 
chicken. Further, the avian leukosis virus (ALV) is the subject of significant 
investigation. 
Chicken Telomerase Activity 
The expression of telomerase in the chicken was the subject of a paper from Carolyn 
Price's laboratory in 1998 (Venkatesan and Price, 1998). They studied tissues from 1- 
day-old chickens, 9-month-old chickens, and a 2-year-old rooster. They looked at 
samples from the testis, kidney, spleen, liver, lung, pancreas, thymus, brain, ovary, and 
heart. Activity was detected in both germ-line and somatic cell types. They also 
observed that telomerase activity was detected in more of the I-day-old tissues than the 
rooster tissues, though they did not test a significant number of older animals to confirm 
this conclusion. Activity was not detected in the heart or brain of the chicken tissue 
samples, suggesting that similar to human, telomerase is repressed in highly 
differentiated organs. These observations were also consistent with the telomerase 
activity profile that has been observed in the mouse, where telomerase activity is found 
in most tissues other than brain and muscular organs (Venkatesan and Price, 1998). 
Chicken embryonic fibroblast telomerase activity was also analyzed. As previously 
mentioned, chicken embryonic fibroblasts have a limited lifespan and undergo 
replicative senescence like human primary cell cultures (Reviewed in Venkatesan and 
Price, 1998), which typically are able to undergo 25-35 population doublings. During 
these studies, chicken cells were passaged until they underwent replicative 
senescence, which occurred between 22 and 32 population doublings. They observed 
a decline in the telomere length with increased population doublings at an average loss 
of 60 bases per population doubling (Venkatesan and Price, 1998). Telomerase activity 
was found to be down-regulated when cultures were established from chicken embryos, 
raising concerns regarding the study of senescence in these chicken err~bryonic cells 
where telomerase up-regulation has typically been observed. Upregulation of 
telomerase activity was shown to occur in transformed cells and tumors from chicken 
origins (Forsyth et al., 2002). 
Chicken Telomerase Genes 
The chicken telomerase RNA subunit, cTR, was cloned by Greider. (Chen, 2000). It was 
identified in a shotgun approach, using degenerate PCR. The cTR, accession NR 
001594, is 465 bases in length, which is very similar to the human TR component of 
451 bases. In fact, the cTR shares significant conservation with hTR, including all of the 
functional and conserved regions. 
At the beginning of this investigation, the chicken telomerase catalytic subunit had not 
yet been identified. Using an in silico approach, a 204 AA open reading frame was 
identified (Figure lo), which shared 73% similarity to hTERT. By comparing the chicken 
TERT (chTERT) homolog sequence to hTERT, several of the critical regions of the 
peptide were found to share conserved sequence, including the E Reverse Telomerase 
motif, which is critical forTERTYs catalytic activity. In addition, sequence towards the C- 
terminus of the TERT protein was present in this EST. 
The hypothesized chTERT cDNA was identified through a BLAST search of the BBSRC 
Chicken EST Database. "This web-site provides access to 339,314 Gallus gallus ESTs 
which were sequenced from 64 cDNA libraries generated from 21 different embryonic 
Alignment of hTERT and cTERT Amino Acid Sequence 
Score = 222 bits (566), Expect = 7e-56 
I d e n t i t i e s  = 112/184 ( 6 0 % ) ,  P o s i t i v e s  = 137/184 (73%) 
hTERT: YARTSIRASLTFNRGFKAGRNMRRKLFGVLRLKCHSLFLDLQVNSLQTVCTNIYKILLLQ 1008 
YA TSIR+SL+FN AG+NM+ KL VL+LKCH L LDL++NSLQTV NIYKI LLQ 
chTERT: YAFTSIRSSLSFNSSRIAGKNMKCKLTAVLKLKCHPLLLDLKINSLQTVLINIYKIFLLQ 80 
hTERT: AYRFHACVLQLPFHQQVWKNPTFFLRVISDTASLCYSILKGPLPSE 1068 
AYRFHACVLQLPF+Q+V NP FFLR+ISDTAS CY ILKAKN G+SLG+K A+G P E 
chTERT: A Y R F H A C V L Q L P F N Q K V R N N P D F F L R I I S D T A S C C Y F I L K F P F E  140 
hTERT: AVQWLCHQAFLLKLTRHRVTYVPLLGSLRTAQTQLSRKLPGTTLTALENPALPSDFK 1128 
A +WLC+ AF++KL+ H+V Y LL L+ + L K+P T+ L+ P+L DFK 
chTERT: AAEWLCYHAFIVKLSNHKVIYKCLLKPLKVYKMHLFGKIPRDTMELLKTVTEPSLCQDEK 200 
hTERT: TILD 1132 
TILD 
chTERT: TILD 204 
Figure 10. Chicken Telomerase Reverse Transcriptase (chTERT) homolog amino 
acid alignment with hTERT. The chicken est, 050049.1, was identified and translated 
into a hypothesized amino acid sequence. This sequence was then compared to the 
hTERT amino acid sequence. An alignment of more than 73 percent similarity was 
identified. This est was later confirmed by Delany et.al. to be the chTERT gene. 
and adult tissues (sequence stats + tissue list). These ESTs were clustered into 64,760 
gene-bins, which were assembled into 85,486 contiguous sequences (contigs)." The 
database was blasted using hTERT sequence. (http:llwww.chick.umist.ac.uW). 
Using the hTERT gene for comparisons, 1 unique EST, 050049.1 (Blast results shown 
in Figure 10) was identified that had significant homology to hTERT. This sequence 
was cloned from adult kidney + adrenal gland, as well as from ovary. Translation of the 
DNA sequence using the ExPASy Proteomics tools at 
http:/lau.ex~as~.or~ltoolsl#translate produced an open reading frame of 204 amino 
acids, which was used for alignment analysis(Figure 11). 
Following the identification of this EST, which likely represented the chicken homolog of 
hTERT, the Delany group confirmed the identity of the chTERT gene (Delany and 
Daniels, 2004). Delany identified the chTERT mRNA from gastrula stage embryos and 
found a 4497 base pair mRNA, which produced a protein of 1346 amino acids residues 
in length. This sequence was submitted to, and accepted by, NCBl and has received 
the accession NM~001031007. 
A thorough analysis of the chTERT gene reveals that the protein sequence of chTERT 
is 45% identical to hTERT (Delany and Daniels, 2004). The chTERT protein has a 
longer N-terminal flexible linker region, which is 144 amino acids longer than what is 
found in the human protein (Delany and Daniels, 2004). Delany mapped chTERT to 
chromosome 2q21 near an interstitial telomere site (Delany and Daniels, 2004). 
8 T 1 2  A B ' C D  E kDa p4 
Tt 133 1 0  0 
Tt=Tetrahymena, Ot=Oxytrica, Ea=Euplotes, Sc=yeast (cerevisiae), Sp=yeast (pombe) 
Figure 11. Comparison of various organisms TERT sequence, with newly 
identified chicken EST sequence aligned. The chTERT est was aligned along with 
the TERT homologs from Tetrahymena, Oxytrica, Euplotes, yeast, mouse and humans. 
The chTERT shared homology to these other TERTs across the E RT motif as well as 
the C terminus. 
Chapter 7 
Discussion and Conclusions 
The study of telomere structure and telomerase biology has been an exciting and 
enlightening field for over 2 decades. The study of how and why we age touches the 
root of the human condition. For thousands of years, humans have sought to evade or 
overcome the reality of fate and old age. Myths such as the fountain of youth or the 
Holy Grail have provided inspiration for those hopeful that someday we will conquer the 
diseases of old age or aging altogether. 
Early insights into telomere biology have given hope that perhaps we have uncovered 
the molecular clock that determines human lifespan. Normal cells, which are normally 
capable of undergoing a finite number of cell divisions, can occasionally extend their 
lifespan and either undergo a process of programmed cell death or activate some type 
of immortalization mechanism. With this came the hope that perhaps we could affect 
longevity through manipulation of molecular processes that lead to telomere shortening, 
i.e. activation of immortalization. With the discovery of telomerase came additional 
insight into how telomeres maintain their lengths and regulate the process of aging. 
This maintenance of telomere length was observed in cells that intuitively would have 
been expected to maintain telomere lengths, such as germ cells and cancer cells. 
The observation of telornerase activity in neoplasia, though intuitive, has lead to a large 
and promising field in cancer research and the development of potential therapies 
targeted at inhibiting telomerase function. Insight into the molecular process leading to 
telomerase re-activation in neoplastic cells has and will continue to lead to new 
understandings of cancer biology in order to define mechanisms and pathways involved 
in telomerase activation. In addition, the process for telomere stabilization in immortal 
cells has allowed for interesting insight into the molecular process of aging. With the 
knowledge that telomerase activity alone is not tumorgenic, there is hope that 
exogenous telomerase activity could artificially extend lifespan. Tissue culture studies 
from a variety of laboratories substantiate this hypothesis in that normal telomerase- 
negative cell strains transfected with exogenous telomerase have substantially 
increased life spans (Bodnar et al., 1998). 
The development of effective models systems for the study of aging and cancer is vital 
to furthering this field of research. Though the mouse has served as an incredibly 
effective model for the study of most human pathology and molecular processes, it 
poses significant challenges in the study of telomere biology, especially as it relates to 
,the aging process. As such, it is critical to the advancement of the telomere field to 
identify new animal models for the study of telomeres and telomerase activity with 
respect to aging and progression to-cancer. 
The chicken has proven to be a valid model for the study of vertebrate embryology and 
development. With several classes of telomere with varying lengths, the chicken has 
telomeres suited to make direct comparisons to humans. The extremely large, class Ill 
telomeres are similar to those of the mouse, posing the same challenges to single 
generation analysis of telomere shortening and cancer development. Of interest is the 
possible chromosome specific effects that are likely to be seen in the chicken 
chromosomes where class II and particularly class I telomeres are present. These 
chromosomes would trigger the damaged DNA response sooner than their counterparts 
with class I11 telomeres. These studies would be particularly interesting if studied in the 
absence of telomerase activity. 
As discussed, the chicken, like the mouse, constitutively expresses telomerase in some 
somatic cells. With the observations by the Hahn laboratory that telomerase maintains 
telomere stability independent of telomere elongation, perhaps the telomerase-negative 
chicken may not be required if the constitutive telomerase activity found in some 
chicken somatic cells serves 'this same stabilizing function. 
The Hahn lab's observations (Matsutomi et al., 2003) are particularly interesting when 
considering the mouse and chicken as animal models. If the constitutive telomerase 
activity serves primarily to maintain telomere stability rather than overall length, then 
perhaps both animals have greater promise as models for the study of telomere and 
telomerase biology. The chicken, with its multiple classes of telomeres would be a 
better model than the mouse in that the first two classes (class 1 and II) of telomere are 
so similar to the length of human telomeres. 
Studies of telomere shortening in the chicken would provide interesting insight into the 
effect of shortening of specific chromosomes. With the varying classes of telomere 
lengths in chickens, the DNA damage response would only be expected to be observed 
in the shorter classes. Dysfunction of the shorter chromosomes, including the 
microchromosomes of the chicken would provide interesting information about specific 
genomic changes caused by specific chromosomal damage. 
Developing a new chicken model for the study of telomeres as they relate to cancer 
progression and potentially aging is a worthy pursuit. The chicken lifespan, telomere 
lengths and time between generations all provide a reason for the development of a 
chicken model. The chicken provides advantages over the traditional mouse model for 
telomere studies and is a worthy alternative model for the study of cancer. 
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